Atlas Trials

Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma

Clinical trial NCT00086034 · COMPLETED

Trial details

NCT number
NCT00086034
Sponsor
Pharmacyclics LLC.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
LymphomaNon-Hodgkin's Lymphoma
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.